777823-76-4 Usage
Uses
Used in Organic Synthesis:
4-(Chloromethyl)-2,5-dimethyl-1,3-oxazole serves as a key building block in organic synthesis, facilitating the construction of complex molecular structures for various applications.
Used in Pharmaceutical Research:
In pharmaceutical research, 4-(Chloromethyl)-2,5-dimethyl-1,3-oxazole is utilized for the synthesis of new drug candidates, contributing to the development of innovative treatments and therapies.
Used in Agrochemical Production:
4-(CHLOROMETHYL)-2,5-DIMETHYL-1,3-OXAZOLE also acts as an intermediate in the production of agrochemicals, playing a crucial role in the synthesis of substances that help protect crops and enhance agricultural productivity.
Used in Pharmaceutical Ingredients:
4-(Chloromethyl)-2,5-dimethyl-1,3-oxazole is employed in the synthesis of pharmaceutical ingredients, contributing to the formulation of new medicines and improving existing ones.
Used in Medicinal Chemistry:
With its potential applications in medicinal chemistry, 4-(Chloromethyl)-2,5-dimethyl-1,3-oxazole aids in the development of novel drugs, targeting a wide range of diseases and health conditions.
It is important to handle 4-(Chloromethyl)-2,5-dimethyl-1,3-oxazole with care due to its potential hazards if not used properly, ensuring safety in research and industrial applications.
Check Digit Verification of cas no
The CAS Registry Mumber 777823-76-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,7,7,8,2 and 3 respectively; the second part has 2 digits, 7 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 777823-76:
(8*7)+(7*7)+(6*7)+(5*8)+(4*2)+(3*3)+(2*7)+(1*6)=224
224 % 10 = 4
So 777823-76-4 is a valid CAS Registry Number.
InChI:InChI=1/C6H8ClNO/c1-4-6(3-7)8-5(2)9-4/h3H2,1-2H3
777823-76-4Relevant academic research and scientific papers
Synthesis and evaluation of a novel series of 2,7-substituted-6-tetrazolyl-1,2,3,4-tetrahydroisoquinoline derivatives as selective peroxisome proliferator-activated receptor γ partial agonists
Morishita, Ko,Ito, Yuma,Otake, Kazuya,Takahashi, Kenji,Yamamoto, Megumi,Kitao, Tatsuya,Ozawa, Shin-Ichiro,Hirono, Shuichi,Shirahase, Hiroaki
, p. 333 - 351 (2021/04/30)
A novel series of 7-substituted-2-[3-(2-furyl)acryloyl]-6-tetrazolyl-1,2,3,4-tetrahydroisoquinoline derivatives were synthesized to clarify structure–activity relationships for peroxisome proliferator-activated receptor γ (PPARγ) partial agonist activity
